Cargando…
Long-term safety and efficacy of etanercept in the treatment of ankylosing spondylitis
To date, anti-tumor necrosis factor alfa (anti-TNF-α) therapy is the only alternative to nonsteroidal anti-inflammatory drugs for the treatment of ankylosing spondylitis. Etanercept is a soluble TNF receptor, with a mode of action and pharmacokinetics different to those of antibodies and distinctive...
Autores principales: | Senabre-Gallego, José Miguel, Santos-Ramírez, Carlos, Santos-Soler, Gregorio, Salas-Heredia, Esteban, Sánchez-Barrioluengo, Mabel, Barber, Xavier, Rosas, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790868/ https://www.ncbi.nlm.nih.gov/pubmed/24101863 http://dx.doi.org/10.2147/PPA.S33109 |
Ejemplares similares
-
Infertility improved by etanercept in ankylosing spondylitis
por: Rezvani, Aylin, et al.
Publicado: (2008) -
Treatment of ankylosing spondylitis: focus on etanercept
por: Frech, Tracy
Publicado: (2007) -
Safety and Clinical Responses in Ankylosing Spondylitis after Three Months of Etanercept Therapy
por: Choi, Chan-Bum, et al.
Publicado: (2008) -
Inefficacy or Paradoxical Effect? Uveitis in Ankylosing Spondylitis Treated with Etanercept
por: Raffeiner, Bernd, et al.
Publicado: (2014) -
Relapsing Polychondritis in a Patient with Ankylosing Spondylitis Using Etanercept
por: Azevedo, Valderilio Feijó, et al.
Publicado: (2014)